The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

1. Aapro, M.
2. De Laurentiis, M.
3. Rea, D.
4. Bargallo Rocha, J.E.
5. Elizalde, R.
6. Landherr, L.
7. Linderholm, B.
8. Mamounas, E.
9. Markopoulos, C.
10. Neven, P.
11. Petrovsky, A.
12. Rouzier, R.
13. Smit, V.
14. Svedman, C.
15. Schneider, D.
16. Thomssen, C.
17. Martin, M.